Pharmaceutical Business Review

Zeit	Aktuelle Nachrichten
09:42	Morphic Therapeutic enters into integrin research and development collaboration with Janssen
09:42	Merck to buy late-stage immunotherapy firm Immune Design for $300m
08:42	Amgen and partners begin second phase 3 trial of omecamtiv mecarbil in patients with heart failure
Do	Sosei Heptares doses first patient in trial targeting endocrine disorders
Do	Indivior introduces generic version of Suboxone opioid drug in US
Do	Peloton Therapeutics secures $150m in Series E financing
Mi	Innovation Pharmaceuticals receives new patent for compounds for use in treatment of oral mucositis
Mi	Roche secures FDA priority review for entrectinib and polatuzumab vedotin
Mi	Merck gets FDA nod for Keytruda as adjuvant treatment for melanoma
Mi	Pfizer secures approval from European Commission for Avastin biosimilar
Di	Innovent, Chipscreen Biosciences to evaluate combination therapy in colorectal cancer patients
Di	Knight signs Latin American strategic funding deal with Moksha8
Di	Additional data analysis offers greater insight into phase 2 findings of Bionomics' PTSD drug
Mo	Decipher announces research collaboration with Dendreon to identify genomic drivers of patient response to Sipuleucel-T
Mo	Bavencio plus Inlyta improves median PFS in renal carcinoma study
Mo	Artificial intelligence can predict survival of ovarian cancer patients
15.02.	FDA declines to approve Motif Bio's iclaprim for ABSSSI treatment
15.02.	SK, Arvelle sign $530m deal for antiepileptic drug cenobamate
15.02.	Vor Biopharma receives $42m funds to advance development of cell therapy product candidate for acute myeloid leukemia
15.02.	Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride
14.02.	World's largest pharmaceutical firm selects ValGenesis to standardize corporate validation process enterprise-level
14.02.	FDA approves Novartis' Egaten to treat fascioliasis
14.02.	Mayne Pharma launches Lexette (halobetasol propionate) foam 0.05% in the US
13.02.	FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer's disease
13.02.	US court rejects Indivior's appeal on Suboxone generic version

Zeit

Aktuelle Nachrichten

09:42

Morphic Therapeutic enters into integrin research and development collaboration with Janssen

09:42

Merck to buy late-stage immunotherapy firm Immune Design for $300m

08:42

Amgen and partners begin second phase 3 trial of omecamtiv mecarbil in patients with heart failure

Sosei Heptares doses first patient in trial targeting endocrine disorders

Indivior introduces generic version of Suboxone opioid drug in US

Peloton Therapeutics secures $150m in Series E financing

Innovation Pharmaceuticals receives new patent for compounds for use in treatment of oral mucositis

Roche secures FDA priority review for entrectinib and polatuzumab vedotin

Merck gets FDA nod for Keytruda as adjuvant treatment for melanoma

Pfizer secures approval from European Commission for Avastin biosimilar

Innovent, Chipscreen Biosciences to evaluate combination therapy in colorectal cancer patients

Knight signs Latin American strategic funding deal with Moksha8

Additional data analysis offers greater insight into phase 2 findings of Bionomics' PTSD drug

Decipher announces research collaboration with Dendreon to identify genomic drivers of patient response to Sipuleucel-T

Bavencio plus Inlyta improves median PFS in renal carcinoma study

Artificial intelligence can predict survival of ovarian cancer patients

15.02.

FDA declines to approve Motif Bio's iclaprim for ABSSSI treatment

15.02.

SK, Arvelle sign $530m deal for antiepileptic drug cenobamate

15.02.

Vor Biopharma receives $42m funds to advance development of cell therapy product candidate for acute myeloid leukemia

15.02.

Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride

14.02.

World's largest pharmaceutical firm selects ValGenesis to standardize corporate validation process enterprise-level

14.02.

FDA approves Novartis' Egaten to treat fascioliasis

14.02.

Mayne Pharma launches Lexette (halobetasol propionate) foam 0.05% in the US

13.02.

FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer's disease

13.02.

US court rejects Indivior's appeal on Suboxone generic version

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von

Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Xetra-Orderbuch

Devisen	Kurs	%

Rohstoffe	Kurs	%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)

Aktuelle News von Pharmaceutical Business Review